[EN] GPR52 MODULATORS AND METHODS OF USE<br/>[FR] MODULATEURS DE GPR52 ET PROCÉDÉS D'UTILISATION
申请人:NEUROCRINE BIOSCIENCES INC
公开号:WO2021216705A1
公开(公告)日:2021-10-28
The present disclosure relates to compounds of Formula (I) that modulate the activity of G-protein coupled receptor 52 (GPR52), pharmaceutically acceptable salts of compounds of Formula (I), and pharmaceutical compositions thereof. Compounds, pharmaceutical salts of compounds, and pharmaceutical compositions of the present disclosure are directed to methods useful in the treatment or prophylaxis of a neurological disease or disorder and conditions related thereto.
本公开涉及式(I)化合物,该化合物调节G蛋白偶联受体52(GPR52)的活性,化合物的药学可接受盐以及其制备的药物组合物。本公开的化合物、化合物的药学盐以及药物组合物,用于治疗或预防神经系统疾病或障碍及相关疾病的方法。